AZD-8330
| Code | Size | Price |
|---|
| SYN-1195-M100 | 100 mg | Enquire |
Quantity:
| SYN-1195-M001 | 1 mg | £127.00 |
Quantity:
| SYN-1195-M005 | 5 mg | £209.00 |
Quantity:
| SYN-1195-M010 | 10 mg | £385.00 |
Quantity:
| SYN-1195-M050 | 50 mg | £1,111.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
4°C
Documents
Further Information
Alternate Names/Synonyms:
AZD8330
Appearance:
Solid.
CAS:
869357-68-6
EClass:
32160000
Form (Short):
liquid
InChi:
InChI=1S/C16H17FIN3O4/c1-9-7-11(15(23)20-25-6-5-22)14(21(2)16(9)24)19-13-4-3-10(18)8-12(13)17/h3-4,7-8,19,22H,5-6H2,1-2H3,(H,20,23)
InChiKey:
RWEVIPRMPFNTLO-UHFFFAOYSA-N
Long Description:
Chemical. CAS: 869357-68-6. Formula: C16H17FIN3O4. MW: 461.2. AZD8330 is a novel, selective, non-ATP competitive MEK 1/2 inhibitor with an IC(50) of 7nM.
Molecular Formula:
C16H17FIN3O4
Molecular Weight:
461.2
Package Type:
Plastic Vial
Product Description:
AZD8330 is a novel, selective, non-ATP competitive MEK 1/2 inhibitor with an IC(50) of 7nM.
Purity:
>95%
Solubility Chemicals:
Soluble in DMSO or ethanol.
Transportation:
Non-hazardous
UNSPSC Category:
Protein Kinase Modulators
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 1 year after receipt when stored at +4°C.
References
A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies: R.B. Cohen, et al.; Eur. J. Cancer 49, 1521 (2013)
Related Products
| Product Name | Product Code | Supplier | PD 184352 | AG-CR1-0029 | AdipoGen Life Sciences | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|